Participating Faculty: Optimal Management of Patients With Cardio-Kidney-Metabolic Syndrome

This supplement was supported by Boehringer Ingelheim Pharmaceuticals, Inc and Lilly USA, LLC.

Faculty

Keith C. Ferdinand, MD

Professor of Medicine

Department of Cardiology

Tulane University School of Medicine

New Orleans, LA

Yehuda Handelsman, MD

Medical Director and Principal Investigator

Metabolic Institute of America

Tarzana, CA

Erin D. Michos, MD, MHS

Associate Director of Preventative Cardiology

Division of Cardiology

Johns Hopkins University School of Medicine

Baltimore, MD

Ian J. Neeland, MD

Associate Professor of Medicine

Case Western Reserve University School of Medicine

Director of Cardiovascular Prevention

Director of Center for Integrated and Novel

Approaches in Vascular-Metabolic Disease

Division of Cardiovascular Medicine

University Hospitals Harrington Heart and Vascular Institute

University Hospitals Cleveland Medical Center

Cleveland, OH

Sanjay Rajagopalan, MD

Director

Professor of Medicine

Cardiovascular Research Institute

Case Western Reserve University School of Medicine

Division Chief

Cardiovascular Medicine

University Hospitals Cleveland Medical Center

Cleveland, OH

Faculty Disclosures

These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.

Keith C. Ferdinand, MD

CONSULTANCIES

Boehringer Ingelheim, Janssen, Lilly, Medtronic, Novartis

Yehuda Handelsman, MD

RESEARCH GRANTS/CONSULTANT AND SPEAKER HONORARIA

89Bio; Amgen; Applied Therapeutics; AstraZeneca; Bayer; Boehringer Ingelheim; Corcept Therapeutics; Endogenex; Esperion; Ionis Pharmaceuticals, Inc; Lilly; Mankind Pharma; Merck; Merck-Pfizer; Novartis; Novo Nordisk; Regeneron Pharmaceuticals, Inc; Sanofi

Erin D. Michos, MD, MHS

CONSULTING FEES

Amgen; Arrowhead Pharmacueticals; Boehringer Ingelheim; Edwards Lifesciences; Esperion; Ionis Pharmaceuticals, Inc; Medtronic; Merck; NewAmsterdam Pharma; Novartis; Novo Nordisk; ZOLL

Ian J. Neeland, MD

HONORARIA, CONSULTING, AND SPEAKERS’ BUREAU FEES

Boehringer Ingelheim/Lilly Alliance

CONSULTING FEES AND HONORARIA

Bayer

PAID SCIENTIFIC ADVISORY BOARD

AMRA Medical, Boehringer Ingelheim, Lilly, Novo Nordisk

Sanjay Rajagopalan, MD

CONSULTING HONORARIA AND ADVISORY BOARD FEES

Bayer, Novo Nordisk